eFFECTOR Therapeutics Inc

NASDAQ:EFTR 3:59:57 PM EDT

0.51

+0.02 (+4.71%)

: $0.49 -0.02 (-4.50%)

Market Cap (Intraday)	21.21M
Current PE	3.76
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.11 Million
Adjusted EPS	-$0.27

See more estimates

10-Day MA	$0.49
50-Day MA	$0.45
200-Day MA	$1.03

See more pivots

eFFECTOR Therapeutics Inc Stock, NASDAQ:EFTR

142 North Cedros Avenue, Suite B, Solana Beach, California 92075

United States of America

Phone: +1.858.925.8215

Number of Employees: 13

http://www.effector.com

Description

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in Solana Beach, CA.